The failure of federal agencies to implement 25 sets of "significant" recommendations from the HHS Office of Inspector General has cost US taxpayers and beneficiaries some $24 billion.
The failure of federal agencies to implement 25 sets of "significant" recommendations from the HHS Office of Inspector General has cost US taxpayers and beneficiaries some $24 billion, says an OIG report released last week.
Some 275 of the recommended actions attribute delays and failures of CMS to follow through to legislative or other obstacles. If implemented, however, the recommended actions would likely improve quality and patient safety, program integrity, financial and grants management, and contractor management, the report says.
Read more at HealthLeaders Media: http://bit.ly/1ETTv5N
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More